Subscribe to NRx Newsletter

Our mission is to bring hope to people with life-threatening diseases through breakthrough science.

We believe people suffering from bipolar, post-traumatic stress syndrome (PTSD), and other psychiatric diseases deserve to return to a full life.  We focus our medicinal pipeline on psychiatric diseases modulated by the NMDA Receptor.  Learn more about the NMDA Receptor ➡️

Bipolar Depression & Suicidality

NRX-101

As many as 50% of individuals with bipolar disorder attempt suicide and between 11-20% of those attempt and succumb to suicide.

In the U.S., more than 100 people per day end their own lives due to bipolar depression in patients with Acute Suicidal Ideation & Behavior (ASIB).

Today, there is no approved medication for the treatment of Bipolar Depression when Suicidality is present.

Learn about Bipolar Depression & Suicidality ➡️

Post Traumatic Stress Disorder (PTSD)

Unlike other anxiety disorders, PTSD is significantly associated with depression and suicidal ideation.

Post-9/11, The United States has lost 4x more veterans and service members to suicide than combat.

Learn about PTSD ➡️

Our Compounds

Research Pipeline

Our Science

Scientific Publications